danthron has been researched along with Amyloid Neuropathy Type 1 in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitakami, R | 1 |
| Inui, K | 1 |
| Nakagawa, Y | 1 |
| Sawai, Y | 1 |
| Katayama, W | 1 |
| Yokoyama, T | 1 |
| Okada, T | 1 |
| Kanamitsu, K | 1 |
| Nakagawa, S | 1 |
| Toyooka, N | 1 |
| Mizuguchi, M | 1 |
1 other study available for danthron and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, | 2021 |